Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This policy A58883 is a billing and coding guideline that complements Local Coverage Determination L39128 for amniotic and placental-derived product injections/applications for non-wound musculoskeletal indications. It does not itself define clinical indications, limitations, documentation requirements, or frequency limits—those are specified in LCD L39128 and should be consulted for coverage determinations.

"This billing and coding guideline does not itself list covered clinical indications; refer to Local Coverage Determination L39128 for covered musculoskeletal (non-wound) indications for amniotic an..."

Sign up to see full coverage criteria, indications, and limitations.